A US company is voluntarily recalling a swathe of hemp tincture products, intended for dog, cat, and human consumption, after the Florida Department of Health tested some samples and found dangerous levels of lead.
Which factors are tipping these THC concentrations over the legal limit? The soil? The sun? The strain? Right now, it’s not entirely clear. But one research group at West Virginia University want to change that.
Up until Green Peaks’ approval, any medical cannabis sold in Rhode Island dispensaries had either been tested by growers, by the dispensaries, or by unlicensed, private labs.
The review has paused over 50 applications from CBD companies hoping to acquire a “novel food” status for their products.
To help decide what to do with the impounded products, state authorities are welcoming input from the public until July 15.
Product testing conducted by the US Food and Drug Administration (FDA) has found that many CBD-infused products on sale in the United States are mislabeled, containing vastly differing amounts of CBD than advertised on the product packaging.